Cortexin after a first ischemic stroke: 12-month cognitive follow-up
Randomized study in people · 2013
- What was studied
- 80 patients after first ischemic stroke, 40 with Cortexin plus standard care and 40 with standard care alone.
- Main finding
- At six months, 18/40 Cortexin recipients and 33/40 controls met the MoCA impairment threshold. At baseline the counts were 27/40 and 32/40. The paper reported significant between-group comparisons from months 6 through 12.
MoCA impairment at 6 months · 18/40 (45%) vs 33/40 (83%) · Cortexin plus standard care vs standard care. · Reported p<0.05
Reported findings and study design
The Oryol study assessed cognition after a first ischemic stroke. Baseline testing occurred during days 1–7. The dissertation gives the same two groups and describes simple randomization.
Population or model 80 patients after first ischemic stroke, 40 with Cortexin plus standard care and 40 with standard care alone.
Dose, route and schedule
10 mg intramuscularly each morning for 10 days, repeated at 3, 6 and 9 months. Both groups received standard care. Testing at baseline and months 3, 6, 9 and 12 included MoCA, MMSE and a ten-word recall test.
Protocol source ↗ · Original journal methods, Results and Figure 1 narrative. The university-hosted dissertation abstract matches the population and regimen.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| MoCA impairment at 6 months | 18/40 (45%) vs 33/40 (83%) | Cortexin plus standard care vs standard care. · Reported p<0.05 |
| MoCA impairment at baseline | 27/40 (68%) vs 32/40 (80%) | The baseline proportions differed before treatment. |
| Delayed word recall | Improved in the Cortexin group | Reported p<0.05 for improvement |
| Immediate word recall | No significant between-group difference | |
| Schulte attention test | The dissertation abstract reports a between-group difference at later visits. | p=0.023 and p=0.016 |
| Modified Rankin and Barthel scores | No clear between-group difference in the dissertation abstract |
The institutional author abstract covers the same 80 participants. See the stroke research page for the archive link.
Source for these results ↗ · Reviewed 2026-11-14
Study limitations and source details
Study limitations
- Baseline MoCA impairment rates differed. The paper describes random assignment but does not establish allocation concealment or masking.
- The active-arm 12-month narrative is ambiguous. The month-six comparison uses explicit denominators. Aleksandrova’s dissertation abstract describes the same cohort.
Related publications may describe some of the same participants or experiments.
Source details
Original journal methods, Results and Figure 1 narrative. The university-hosted dissertation abstract matches the population and regimen.
Sources checked
Citation
M. A. Evzelman, N. A. Aleksandrova. Cortexin after a first ischemic stroke: 12-month cognitive follow-up Korsakov Journal of Neurology and Psychiatry. 2013;113(10):36–39.